UK markets closed

Novo Nordisk A/S (NVO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
126.73-1.13 (-0.88%)
At close: 04:00PM EDT
126.90 +0.17 (+0.13%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 565.63B
Enterprise value 568.19B
Trailing P/E 43.83
Forward P/E 37.31
PEG ratio (5-yr expected) 2.23
Price/sales (ttm)16.02
Price/book (mrq)39.28
Enterprise value/revenue 16.00
Enterprise value/EBITDA 31.53

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 357.33%
S&P500 52-week change 318.96%
52-week high 3148.15
52-week low 378.19
50-day moving average 3138.35
200-day moving average 3119.53

Share statistics

Avg vol (3-month) 33.93M
Avg vol (10-day) 34.27M
Shares outstanding 53.38B
Implied shares outstanding 64.46B
Float 83.19B
% held by insiders 10.00%
% held by institutions 19.77%
Shares short (15 Jul 2024) 43.15M
Short ratio (15 Jul 2024) 40.83
Short % of float (15 Jul 2024) 40.10%
Short % of shares outstanding (15 Jul 2024) 40.07%
Shares short (prior month 14 Jun 2024) 44.36M

Dividends & splits

Forward annual dividend rate 41.37
Forward annual dividend yield 41.08%
Trailing annual dividend rate 39.40
Trailing annual dividend yield 37.35%
5-year average dividend yield 41.55
Payout ratio 447.42%
Dividend date 302 Apr 2024
Ex-dividend date 422 Mar 2024
Last split factor 22:1
Last split date 320 Sept 2023

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 36.55%
Operating margin (ttm)48.73%

Management effectiveness

Return on assets (ttm)25.24%
Return on equity (ttm)99.87%

Income statement

Revenue (ttm)244.24B
Revenue per share (ttm)54.60
Quarterly revenue growth (yoy)22.50%
Gross profit (ttm)N/A
EBITDA 117.85B
Net income avi to common (ttm)89.28B
Diluted EPS (ttm)2.89
Quarterly earnings growth (yoy)28.20%

Balance sheet

Total cash (mrq)9.3B
Total cash per share (mrq)2.09
Total debt (mrq)26.93B
Total debt/equity (mrq)27.22%
Current ratio (mrq)0.70
Book value per share (mrq)22.18

Cash flow statement

Operating cash flow (ttm)93.41B
Levered free cash flow (ttm)40.24B